Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychosocial function after hematopoietic stem cell transplantation.

Grace Chang1, E John Orav, Tay K McNamara

  • 1Department of Psychiatry, Brigham and Women's Hospital Boston, MA 02115, USA. gchang@partners.org

Psychosomatics
|March 16, 2005
PubMed
Summary

Quality of life and mood improve for patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation. Alcohol consumption also decreases over time, indicating positive patient recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIV.

JAMA network open·2026
Same author

Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries.

JAMA network open·2026
Same author

Racial and ethnic disparities in GLP-1 prescriptions among veterans with obesity across direct and community care settings.

Health affairs scholar·2026
Same author

Chronic Conditions and Mortality in Medicare Beneficiaries Before and After the COVID-19 Pandemic.

JAMA network open·2026
Same author

Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV.

JAMA network open·2026
Same author

Engagement and Weight Change in an Online Weight Management Program in Clinical Settings: An Implementation Project.

Journal of general internal medicine·2026

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Allogeneic hematopoietic stem cell transplantation (HSCT) is a critical treatment for chronic myelogenous leukemia (CML).
  • Patient-reported outcomes like quality of life (QOL) and mood are crucial in assessing treatment success.
  • Alcohol consumption is a modifiable behavior with potential impacts on health outcomes post-transplantation.

Purpose of the Study:

  • To prospectively evaluate the longitudinal changes in quality of life and mood in CML patients undergoing allogeneic HSCT.
  • To assess patterns of alcohol consumption and their progression during the follow-up period after HSCT.
  • To identify factors influencing QOL, mood, and alcohol use post-transplantation.

Main Methods:

  • Prospective cohort study design.

Related Experiment Videos

  • Serial assessments of QOL, mood (depressive symptoms), and alcohol consumption at admission, 6 months, and 12 months post-HSCT.
  • Inclusion of 84 patients who completed initial assessments and follow-up.

    • Main Results:

    • Significant improvements in overall quality of life were observed over 12 months.
    • A decline in measures of depressive symptoms was noted during the follow-up period.
    • Patients demonstrated a reduction in overall alcohol consumption by the 12-month follow-up.

    Conclusions:

    • Time is a significant factor in the positive recovery trajectory of CML patients post-HSCT.
    • Allogeneic HSCT may lead to improved psychological well-being and healthier lifestyle choices, including reduced alcohol intake.
    • Longitudinal monitoring of QOL, mood, and behavior is essential for comprehensive patient care after transplantation.